Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23630526)

1.

Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Zaunders J, van Bockel D.

Front Immunol. 2013 Apr 24;4:95. doi: 10.3389/fimmu.2013.00095. eCollection 2013.

2.

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.

Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS.

Retrovirology. 2008 Dec 11;5:112. doi: 10.1186/1742-4690-5-112.

3.

The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.

López M, Peris A, Soriano V, Lozano S, Vicario JL, Rallón NI, Restrepo C, Benito JM.

Immunology. 2011 Nov;134(3):305-13. doi: 10.1111/j.1365-2567.2011.03490.x.

4.

Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.

Gaardbo JC, Hartling HJ, Ronit A, Thorsteinsson K, Madsen HO, Springborg K, Gjerdrum LM, Birch C, Laye M, Ullum H, Andersen ÅB, Nielsen SD.

PLoS One. 2013 May 16;8(5):e63744. doi: 10.1371/journal.pone.0063744. Print 2013.

5.

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.

Rodés B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM, Jimenez V, Wrin T, Bassani S, Soriano V.

AIDS. 2004 May 21;18(8):1109-16.

PMID:
15166526
6.

Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression.

Ling B, Veazey RS, Hart M, Lackner AA, Kuroda M, Pahar B, Marx PA.

AIDS. 2007 Nov 30;21(18):2377-85.

PMID:
18025874
7.

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.

Meijerink H, Indrati AR, van Crevel R, Joosten I, Koenen H, van der Ven AJ.

BMC Infect Dis. 2014 Dec 13;14:683. doi: 10.1186/s12879-014-0683-0.

8.

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, Kaldor JM.

AIDS. 1997 Dec;11(15):1833-8.

PMID:
9412701
9.

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14.

10.

The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Migueles SA, Laborico AC, Imamichi H, Shupert WL, Royce C, McLaughlin M, Ehler L, Metcalf J, Liu S, Hallahan CW, Connors M.

J Virol. 2003 Jun;77(12):6889-98.

11.

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.

Carotenuto P, Looij D, Keldermans L, de Wolf F, Goudsmit J.

AIDS. 1998 Sep 10;12(13):1591-600.

PMID:
9764777
13.

Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT Jr, Connors M, Migueles SA.

J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.

14.

Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.

Mandalia S, Westrop SJ, Beck EJ, Nelson M, Gazzard BG, Imami N.

PLoS One. 2012;7(2):e29844. doi: 10.1371/journal.pone.0029844. Epub 2012 Feb 20.

15.

Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.

Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H.

J Immunol. 2007 Sep 1;179(5):3133-43.

16.

CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.

Migueles SA, Mendoza D, Zimmerman MG, Martins KM, Toulmin SA, Kelly EP, Peterson BA, Johnson SA, Galson E, Poropatich KO, Patamawenu A, Imamichi H, Ober A, Rehm CA, Jones S, Hallahan CW, Follmann DA, Connors M.

EBioMedicine. 2014 Dec 22;2(1):46-58. doi: 10.1016/j.ebiom.2014.12.009. eCollection 2015 Jan.

17.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
18.
19.

Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.

Pernas M, Casado C, Sandonis V, Arcones C, Rodríguez C, Ruiz-Mateos E, Ramírez de Arellano E, Rallón N, Del Val M, Grau E, López-Vazquez M, Leal M, Del Romero J, López Galíndez C.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):225-31. doi: 10.1097/QAI.0b013e31829bdc85.

PMID:
23714744
20.

Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.

Ballana E, Ruiz-de Andres A, Mothe B, Ramirez de Arellano E, Aguilar F, Badia R, Grau E, Clotet B, del Val M, Brander C, Esté JA.

Immunobiology. 2012 Sep;217(9):889-94. doi: 10.1016/j.imbio.2011.12.012. Epub 2012 Jan 8.

PMID:
22333575
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk